Dr. Mustafa Khasraw, M.D.
Claim this profileDuke University Medical Center
Area of expertise
Glioblastoma
Mustafa Khasraw, M.D. has run 7 trials for Glioblastoma. Some of their research focus areas include:
Brain Cancer
Mustafa Khasraw, M.D. has run 5 trials for Brain Cancer. Some of their research focus areas include:
Affiliated Hospitals
Duke University Medical Center
The Preston Robert Tisch Brain Tumor Center At Duke University
Clinical Trials Mustafa Khasraw, M.D. is currently running
BRiTE
for Glioblastoma
This trial is testing a new treatment called BRiTE for patients with aggressive brain cancer that have a specific mutation. BRiTE helps the immune system recognize and destroy cancer cells by connecting immune cells directly to the cancer.
Recruiting
1 award
Phase 1
Safusidenib
for Brain Cancer
This trial is testing a new oral medication called safusidenib for patients with certain types of brain tumors that have not responded to other treatments. The drug works by targeting a specific gene mutation to slow down tumor growth. The study will evaluate the safety and effectiveness of different doses of the medication.
Recruiting
1 award
Phase 3
20 criteria
More about Mustafa Khasraw, M.D.
Clinical Trial Related
6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Mustafa Khasraw, M.D. has experience with
- Temozolomide
- HEGFRvIII-CD3 (BRiTE)
- Evolocumab
- CDX-527
- Berubicin
- Lomustine
Breakdown of trials Mustafa Khasraw, M.D. has run
Glioblastoma
Brain Cancer
Diffuse Hemispheric Glioma
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mustafa Khasraw, M.D. specialize in?
Mustafa Khasraw, M.D. focuses on Glioblastoma and Brain Cancer. In particular, much of their work with Glioblastoma has involved MET positive patients, or patients who are IDH positive.
Is Mustafa Khasraw, M.D. currently recruiting for clinical trials?
Yes, Mustafa Khasraw, M.D. is currently recruiting for 2 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Mustafa Khasraw, M.D. has studied deeply?
Yes, Mustafa Khasraw, M.D. has studied treatments such as Temozolomide, hEGFRvIII-CD3 (BRiTE), Evolocumab.
What is the best way to schedule an appointment with Mustafa Khasraw, M.D.?
Apply for one of the trials that Mustafa Khasraw, M.D. is conducting.
What is the office address of Mustafa Khasraw, M.D.?
The office of Mustafa Khasraw, M.D. is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.